GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma
Clinical trial NCT07670260 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07670260
- Sponsor
- Chinese PLA General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2027-09-30
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.